Cavapro is indicated for:
Management of essential hypertension (high blood pressure)
Treatment of hypertensive renal disease in patients with type 2 diabetes, as part of a comprehensive antihypertensive regimen
Irbesartan, the active ingredient in Cavapro, is an angiotensin II receptor antagonist. It selectively blocks AT1 receptors, thereby inhibiting the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in blood pressure reduction and renal protection, particularly in diabetic patients.
Adults:
Type 2 Diabetic Patients with Renal Disease:
Elderly:
Children & Adolescents:
Common:
Headache, dizziness, fatigue, nausea, vomiting
Less Common:
Anxiety, GI discomfort, muscle pain, unusual tiredness
Cavapro has a low risk of cough, unlike ACE inhibitors.
Keep in a cool, dry place, away from direct light.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.